Detailed Information on Publication Record
2004
ICOS deficiency in patients with common variable immunodeficiency
SALZER, Ulrich, Andrea MAUL-PAVICIC, Charlotte CUNNINGHMA-RUNDLES, Simon URSCHEL, Berd BELOHRADSKY et. al.Basic information
Original name
ICOS deficiency in patients with common variable immunodeficiency
Name in Czech
Deficit ICOS u pacientů s běžným variabilním imunodeficitem
Authors
SALZER, Ulrich (276 Germany), Andrea MAUL-PAVICIC (276 Germany), Charlotte CUNNINGHMA-RUNDLES (840 United States of America), Simon URSCHEL (276 Germany), Berd BELOHRADSKY (276 Germany), Jiří LITZMAN (203 Czech Republic, guarantor), Are HOLM (276 Germany), José Luis FRANCO (170 Colombia), Alessandro PLEBANI (380 Italy), Lennart HAMMARSTROM (752 Sweden), Andrea SKRABL (40 Austria), Wolfgang SCHWINGER (276 Germany) and Bodo GRIMBACHER (276 Germany)
Edition
Clin Immunol, 2004, 1521-6616
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30102 Immunology
Country of publisher
Sweden
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 3.034
RIV identification code
RIV/00216224:14110/04:00030933
Organization unit
Faculty of Medicine
UT WoS
000224975700004
Keywords in English
CVID; ICOS; Immunodeficiency
Tags
Změněno: 2/4/2010 08:13, prof. MUDr. Jiří Litzman, CSc.
V originále
Common variable immunodeficiency (CVID) is the most frequent clinically significant primary antibody deficiency in man, predisposing to recurrent bacterial infections. Recently, we showed that the homozygous loss of the inducible costimulator (ICOS) on activated T cells may result in an adult onset form of CVID with autosomal recessive inheritance (AR-CVID). We screened 181 sporadic CVID patients and 13 CVID patients from nine families with AR-CVID for mutations in ICOS by genomic DNA sequencing. In the AR-CVID families, the genomic integrity of the ligand for ICOS (ICOS-L) was also evaluated. In two of the nine AR-CVID families, we identified five individuals with ICOS deficiency, carrying the identical large genomic deletion of ICOS as previously described. In the remaining seven AR-CVID families, we subsequently sequenced the coding region of the ICOS ligand but found no mutations. The incidence of ICOS deficiency among patients with CVID is less than 5%. Worldwide, there are now a total of nine patients diagnosed with ICOS deficiency most likely due to a common founder. ICOS-L deficiency could not be identified in families with AR-CVID
In Czech
Výskyt mutace genu ICOS u pacientů s běžným variabilním imunodeficitem.